For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
235.4 ZAR | +2.42% | +2.11% | +15.65% |
Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
JOHANNESBURG (Reuters) - South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales.
For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
235.4 ZAR | +2.42% | +2.11% | 5.75B | ||
151.3 USD | +0.03% | -0.23% | 364B | ||
1st Jan change | Capi. | |
---|---|---|
+15.65% | 5.75B | |
+22.35% | 44.12B | |
+22.22% | 22.61B | |
+17.96% | 15.11B | |
+15.73% | 13.61B | |
+57.91% | 13.34B | |
-8.98% | 6.94B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.11% | 4.78B |